Início > > Resultado da busca

Resultados: 2

Clinical and laboratorial profile of patients with ATTR cardiomyopathy: comparison between wild type and pVal142Ile forms in the Brazilian population

Simoes, M; Jadan, G; Correia, E. B; Carvalho, A. A. S; Macedo, A. V. S; Schwartzmann, P. V; Scheinberg, P; Antunes, M. O; Coelho-Filho, O. R; Mangini, S; Coneglian, F. S; Valicelli, F. H; Garibaldi, P. M. M; Marques-Junior, W; Fernandes, F Heart.
Eur. heart j; 45 (Suppl. 1), 2024
BACKGROUND: In Brazil, besides the wild type (wt) form, transthyretin amyloid cardiomyopathy (ATTR-CM) is predominantly caused by hereditary form with Val142Ile mutation. Considering that both forms occur in elderly people, the clinical presentation may be similar. We sought to compare the clinical prese...
Negro ou Afro-Americano, Prevalência, Pré-Albumina, Cardiomiopatias, Amiloide
Texto completo

World heart federation consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Brito, Dulce; Albrecht, Fabiano Castro; de Arenaza, Diego Perez; Bart, Nicole; Better, Nathan; Carvajal-Juarez, Isabel; Conceição, Isabel; Damy, Thibaud; Dorbala, Sharmila; Fidalgo, Jean-Christophe; Rapezzi, Claudio; Ueda, Mitsuharu; Pinto, Fausto J; Garcia-Pavia, Pablo; Ge, Junbo; Gillmore, Julian; Grzybowski, Jacek; Obici, Laura Pavia; Piñero, Daniel.
Glob. heart (Online); 18 (1), 2023
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-relate...
Pré-Albumina, Amiloide, Cardiomiopatias, Consenso
Texto completo